|
Clinical Trial Databases Provide Risks, Benefits, GSK Exec Says
Drugmakers can reduce their liability risks and avoid other pitfalls associated with establishing clinical trial databases by using a review team to ensure the trial results are complete and free of promotional claims, says a GlaxoSmithKline (GSK) executive. This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives